Biotech

Promosome Announces the Appointments of Edward R. Robinson and Loren A. Busby to Its Board of Managers

NEW YORK, NY: ...

Poniard Pharmaceuticals Announces Shareholders Approve Merger With ALLOZYNE

SAN FRANCISCO, CA: 1-for-40 Reverse Stock Split of Poniard Common Stock to Be Effective at 5:00 PM, Pacific Time, on November 22, 2011 ...

Warnex Reaches Agreement to Extend Maturity Date of All Its Outstanding Debentures and to Obtain Additional Financing

LAVAL, QUEBEC: ...

Agile Therapeutics Honored as the 2011 Life Sciences Company of the Year by the New Jersey Technology Council

PRINCETON, NJ: ...

Edge Therapeutics Appoints James J. Loughlin to Board of Directors

NEW PROVIDENCE, NJ: Former Partner and Board Member at KPMG LLP Becomes Director ...

Genisphere Licenses RNA Amplification and MicroRNA Labeling Technologies to Affymetrix

HATFIELD, PA: ...

Aldagen Announces Publication of Mechanism of Action Data for Its Cardiovascular Cell Therapy Products

DURHAM, NC: Publication in Journal of Stem Cell Research & Therapy Supports the Potential of Aldagen's Cellular Therapies to Improve Blood Flow in Ischemic Tissues ...

MedImmune Brings Home ISPE Facility of the Year Award for $250 Million Frederick Manufacturing Investment, an Industrial Info News Alert

SUGAR LAND, TX: ...

Real Endpoints Invests in Market Research Firm Reimbursement Intelligence

MADISON, NJ: Providing Solutions for Pharma and Device Companies Challenged by Increasingly Complex Reimbursement Environment ...

PharmaGap Announces Start of Definitive Animal Efficacy Study Required to Proceed to Clinical Trials

OTTAWA, ONTARIO: ...